{"id":49344,"date":"2025-08-07T02:41:26","date_gmt":"2025-08-07T02:41:26","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/49344\/"},"modified":"2025-08-07T02:41:26","modified_gmt":"2025-08-07T02:41:26","slug":"guess-which-asx-healthcare-stock-is-rocketing-42-on-pro-medicus-investment","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/49344\/","title":{"rendered":"Guess which ASX healthcare stock is rocketing 42% on Pro Medicus investment"},"content":{"rendered":"

\"Researchers<\/p>\n

Image source: Getty Images<\/p>\n

4DMedical Ltd (ASX: 4DX<\/a>) shares are having a strong finish to the week.<\/p>\n

In morning trade, the respiratory imaging technology company’s shares are up a massive 42% to 34 cents.<\/p>\n

This follows the release of a big announcement<\/a> from the ASX healthcare stock after the market close on Thursday.<\/p>\n

What did the ASX healthcare stock announce? <\/p>\n

Investors have been scrambling to buy 4DMedical’s shares this morning after it revealed a significant investment from health imaging giant Pro Medicus Ltd (ASX: PME<\/a>).<\/p>\n

According to the release, Pro Medicus will provide the ASX healthcare stock with $10 million via a facility agreement that includes security as collateral.<\/p>\n

The release notes that this strategic investment will provide 4DMedical with growth capital to accelerate its commercial pipeline for existing products while advancing CT:VQ towards regulatory clearance in the United States.<\/p>\n

What does 4DMedical do? <\/p>\n

4DMedical is behind the patented XV Technology, which is a platform that dynamically quantifies ventilation throughout the lungs as patients breathe.<\/p>\n

This technology underpins the company’s FDA-cleared XV Lung Ventilation Analysis Software (XV LVAS) and its CT LVAS, empowering physicians to detect and monitor regional airflow abnormalities with unparalleled sensitivity.<\/p>\n

The company notes that its solutions integrate seamlessly into existing hospital infrastructure via its Software as a Service (SaaS) model, transforming routine imaging into powerful diagnostic tools.<\/p>\n

What are the terms? <\/p>\n

At maturity, the ASX healthcare stock will pay and\/or issue the following to Pro Medicus:<\/p>\n

(i) Cash equal to the higher of: a. $12.5m; and b. $10m x (4DX 10-day VWAP at maturity) \/ (4DX 10-day VWAP at execution), capped at $20m. plus (ii) 4DX shares equal to: ($10m x (4DX 10-day VWAP at maturity \/ 4DX 10-day VWAP at execution) \u2013 $20m) \/ 4DX 10-day VWAP at maturity.<\/p>\n

Commenting on the deal, the ASX healthcare stock’s founder managing director and CEO, Andreas Fouras, said:<\/p>\n

Pro Medicus is a global leader in healthcare, and we are thrilled to receive their support at this pivotal moment in our journey. This strategic investment places us in a very strong position to take CT:VQ to market once it is cleared by the FDA. 4D stands at a very exciting moment, with rapid growth in sites and scans month on month against a backdrop of falling costs.<\/p>\n

Add to this the growing momentum in the Philips partnership, and the shortening timeline to expected FDA clearance of CT:VQ, we are set for extremely strong performance over the coming months.<\/p>\n","protected":false},"excerpt":{"rendered":"Image source: Getty Images 4DMedical Ltd (ASX: 4DX) shares are having a strong finish to the week. In…\n","protected":false},"author":2,"featured_media":49345,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,13955,137,500,7037,7038,7039,7040,41916,36742],"class_list":["post-49344","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-category-healthcare-shares","tag-health","tag-healthcare","tag-partner-feeds-msn-9","tag-partner-feeds-newstex","tag-partner-feeds-sharesight","tag-partner-feeds-webull","tag-tickers_global-asx-4dx","tag-tickers_global-asx-pme"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/49344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=49344"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/49344\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/49345"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=49344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=49344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=49344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}